A French appeals court Wednesday upheld a ruling ordering pharmaceutical giant GlaxoSmithKline to pay 197,000 euros to a man who claimed that its drug to treat Parkinson\'s turned him into a gay sex and gambling addict. The court in the northern city of Rennes said father-of-two Didier Jambart had suffered side effects after being administered the drug Requip in 2003 for the illness, which causes tremors, slows movement and disrupts speech. A court in the western city of Nantes had previously ordered the British drug company to pay 117,000 euros ($151,000) in compensation in March. Jambart, who was accompanied by his wife, burst into tears after the ruling. \"It\'s a great day,\" he said. \"It\'s been a seven-year battle with our limited means for recognition of the fact that GSK lied to us and shattered our lives.\" Jambart, 52, said the drug made him addicted to Internet gambling and caused him to lose the family\'s savings and steal to feed the habit that cost him 82,000 euros. He said he attempted suicide eight times and became a compulsive gay sex addict, exposing himself on the Internet and cross-dressing. His risky sexual encounters led to him being raped. All that stopped when he ceased taking Requip in 2005. Requip has been known for years to have undesired side effects but a warning only appeared on its package insert in 2006, his lawyers said.
GMT 01:03 2018 Wednesday ,24 January
Trump 'imitates' Modi's accent in private conversation: ReportGMT 21:24 2018 Tuesday ,23 January
Puigdemont accuses EU of not defending rights in CataloniaGMT 21:18 2018 Tuesday ,23 January
Vietnam oil exec 'kidnapped' from Germany jailed for lifeGMT 21:08 2018 Tuesday ,23 January
Turkey in new assault on Kurdish militiaGMT 21:04 2018 Tuesday ,23 January
Turkey detains 24 over 'terror propaganda'GMT 20:52 2018 Tuesday ,23 January
Dawoodi Bohra leader arrives in DubaiGMT 22:09 2018 Monday ,22 January
Israel apologises to JordanGMT 16:11 2018 Sunday ,21 January
Pope condemns criminals in crime-stricken Peruvian city

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor